Galapagos NV ADR (GLPG)

Galapagos NV ADR News

• Galapagos ADR earnings beat by $0.03, revenue topped estimates

  • ByInvesting.com
  • •Feb 24, 2023

  Investing.com - Galapagos ADR (NASDAQ: GLPG) reported fourth quarter EPS of $-0.62, $0.03 better than the analyst estimate of $-0.65. Revenue for the quarter came in at $168.57M...

• Galapagos ADR Earnings, Revenue Beat in Q2

  • ByInvesting.com
  • •Aug 05, 2022

  Investing.com - Galapagos (NASDAQ:GLPG) ADR reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that topped expectations. Galapagos ADR...

• Scientists uncover history of 'ridiculously charming' penguins

  • ByReuters
  • •Jul 19, 2022

  By Will Dunham WASHINGTON (Reuters) - The evolution of penguins from their flying seabird ancestors into the flightless denizens of marine environments from frigid Antarctica to...

Galapagos NV ADR Analysis

• Gilead (GILD) Ups Revenue Guidance on Increased Veklury Demand

  • ByZacks Investment Research
  • •Jan 12, 2021

  Gilead Sciences (NASDAQ:GILD), Inc. GILD revised its annual guidance for 2020 as the worsening of the coronavirus pandemic drove sales for Veklury (remdesivir). Total product sales...

• Gilead, Galapagos Announce Positive Data on Inflammatory Drug

  • ByZacks Investment Research
  • •May 21, 2020

  Gilead Sciences (NASDAQ:GILD), Inc. GILD and partner Galapagos (NASDAQ:GLPG) NV GLPG announced positive topline results from a late-stage study on its investigational, oral,...

• Gilead (GILD) Partners With Eisai For RA Candidate In Japan

  • ByZacks Investment Research
  • •Dec 26, 2019

  Gilead Sciences, Inc. (NASDAQ:GILD) announced that it has entered into an agreement with Eisai Co., Ltd for the distribution and co-promotion of its investigational, oral,...